(19)
(11) EP 4 522 761 A1

(12)

(43) Date of publication:
19.03.2025 Bulletin 2025/12

(21) Application number: 23803918.4

(22) Date of filing: 06.05.2023
(51) International Patent Classification (IPC): 
C12Q 1/04(2006.01)
C12Q 1/6851(2018.01)
A61P 9/00(2006.01)
C12Q 1/689(2018.01)
A61K 35/741(2015.01)
A61K 45/06(2006.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/689; C12Q 1/6883; A61P 9/00
(86) International application number:
PCT/QA2023/050005
(87) International publication number:
WO 2023/219522 (16.11.2023 Gazette 2023/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 09.05.2022 US 202263339698 P

(71) Applicant: Sidra Medical And Research Center
Doha (QA)

(72) Inventors:
  • AL KHODOR, Souhaila
    26999 Doha (QA)
  • MURUGESAN, Selvasankar
    26999 Doha (QA)
  • EL ANBARI, Mohammed
    26999 Doha (QA)
  • TERRANEGRA, Annalisa
    26999 Doha (QA)

(74) Representative: K&L Gates LLP 
Friedrichstraße 110 A
10117 Berlin
10117 Berlin (DE)

   


(54) THE SALIVARY MICROBIOME IN CARDIOVASCULAR DISEASE